Abstract :
[en] Vascular calcification is a marker of cardiovascular risk increase. Age and specific disease such as diabetes or chronic kidney disease are important factors for calcification genesis. Vascular calcification process is a complex phenomenon, involving several activators and inhibitors factors. Indeed, recent works related to in vitro and in vivo experimental studies have led to a better understanding of calcification process and identification of molecules able to modulate this system. This revue will summarize some of these molecules with a particular interest of those with therapeutic relevance. We will present: i) calcium sensing receptor and its modulation by cinacalcet; ii) pyrophosphate supplementation; iii) fetuin A and overall propensity serum test for calcification and finally; iv) matrix-Gla-protein and the use of vitamin K to prevent vascular calcification progression.
Commentary :
Groupe de travail : J. Arnaud and Ph. Zaoui, CHU Grenoble ; M.C. Carlier, M. Laville and D. Fouque CHU Lyon ; E. Cavalier and P. Delanaye, CHU Sart-Tilaman Liège ; J.P. Cristol and A.S. Bargnoux, CHU Montpellier ; S. Kamel, Université de Picardie, Z. Massy, Ambroise Paré et UVSQ Paris ; et Inserm U-1088 et Université de Picardie, D. Prié, P. Urena-Torres and J.C. Souberbielle, Inserm/Université U 845 ; A. Boutten, APHP - GH Paris Nord Val de Seine ; A. Guérin, CH de Manhes ; T. Hannedouche, CHU Strasbourg, Ph. Brunet CHU Marseille ; G. Jean, Nephrocare Tassin-Charcot ; M.H. Lafage-Proust CHU St Etienne ; G. London, Inserm U970 ; L. Mercadal, Pitié Salpêtrière Paris ; L. Pieroni, CH Avignon
Scopus citations®
without self-citations
0